Published: July 2020
Proteome profiling is a technically complex and financially demanding field of research; as a result, both pharmaceutical companies and research institutes prefer to rely on specialty service providers that claim to have the required expertise
With the growing prominence of peptide-based therapeutics and personalized medicine, there is an increased demand for rapid, highly sensitive, and accurate quantification methods to analyze clinical specimens. As a result, proteome profiling has become an indispensable part of modern drug discovery and development process, as well as disease diagnosis.
To order this 290+ page report, which features 50+ figures and 100+ tables, please visit this link
More than 210 players presently claim to offer a variety of services for proteome profiling
Majority of the service providers offer protein identification (99%) and protein quantification (82%) services. Based on application area, most of the players claim to provide services for drug development (over 75%); followed by those offering proteome profiling for disease diagnosis (39%).
Over 80% proteome profiling service providers are based in North America and Europe
Within North America, majority (91%) of the players are headquartered in the US, whereas, in Europe, most of the companies are based in (in decreasing order of number of service providers) Germany (6), UK (2), Switzerland (2) and Sweden (2).
Partnership activity within this domain has grown at a CAGR of 38%, between 2014 and 2019
Maximum number of partnerships were observed in 2019. Further, majority of the agreements signed with this domain were reported to be service alliances and technology licensing agreements, representing over 55% of the total instances.
North America and Europe are anticipated to capture over 70% of the overall market share by 2030
In the long term, the market in Asia Pacific is expected to grow at a relatively faster pace. Further, in terms of type of sponsor, pharmaceutical companies represent the highest share and this trend is unlikely to change in the foreseen future.
To request a sample copy / brochure of this report, please visit this link
The USD 16 billion (by 2030) financial opportunity within the proteome profiling services market has been analyzed across the following segments:
The report features inputs from eminent industry stakeholders, according to whom, in terms of application area, the market for proteome profiling services intended for disease diagnosis is likely to grow at a relatively faster pace. The report includes detailed transcripts of discussions held with the following experts:
The research covers profiles of key players (listed below) offering proteome profiling services; each profile features an overview of the company, its service portfolio, details on proteome profiling-related services and technologies offered, recent developments, and an informed future outlook.
For additional details, please visit
or email firstname.lastname@example.org
You may also be interested in the following titles:
+1 (415) 800 3415
+44 (122) 391 1091
We are your partners with no equity
We fit in your budget
We love what we do
Chance to prove ourselves
Best in class quality of work
Most trusted consulting partner in the industry